Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The CHEILECTOMY market is influenced by the rising incidence of hallux rigidus, a common degenerative condition affecting the big toe. As the population ages, the prevalence of this condition is expected to grow, driving the demand for surgical interventions like cheilectomy.
Advances in surgical techniques and technologies play a pivotal role in shaping the CHEILECTOMY market. Innovations such as minimally invasive procedures, arthroscopy, and improved instrumentation contribute to reduced recovery times and better patient outcomes, thereby influencing the market dynamics.
Furthermore, some factors including the development of the technology also lead to the rising of non-surgical solutions for the treatment of hallux rigidus, such as physical therapy and orthotics. The switching of patients to newer techniques results in a change of demand for cheilectomy procedure, therefore the makers and health care providers will be required to adapt to the evolution of patients' needs.
Through the reimbursement environment stands as the main parts whether the market of CHEILECTOMY is increasing or stable. When it comes to healthcare policies and reimbursement it becomes also the case that the accessibility and prices of cheilectomy methods for patients may be affected. Market actors keenly follow these policies in the course of procedures to draw up challenge maps and to take up the resulting business opportunities.
The labor market of this orthopedic operation is as good as the availability of the experienced orthopedic surgeons who can professionally do a cheilectomy procedure. The programs which train surgeons and the continuous medical education bring to the fore imply a high level of expertise that is also one of the factors underlying the trend of the CHEILECTOMY market.
Participations of medical device manufacturers, pharmaceutical companies, and healthcare organizations influences the development of the HEHRISCOPE industry. With regard to the joint work in research as well as development, it can be noted that this will result in the development of more effective types of surgical tools, implants as well as the care of a patient post the surgery, therefore leading to an increase in market growth.
Both patients knowledge and the demand for cheilectomy are closely related to patients' awareness of the disease and treatment alternatives. Educational efforts carried out by healthcare institutions and manufacturers are striving to make patients opt for decision making that is setting the trend and impacts positively on the market by increasing the number of surgical interventions.
Effective postoperative rehabilitation is vital for the success of cheilectomy procedures. The development and adoption of standardized rehabilitation protocols impact patient recovery and satisfaction, influencing the market through word-of-mouth referrals and enhanced patient outcomes.
Cheilectomy Market Highlights:
Cheilectomy Market Scenario:
The cheilectomy market is expected to grow USD 8.45 billion at a CAGR of 7.8% during the forecast period 2023-2030. Cheilectomy is a surgical procedure aimed to remove the bony lump present on the top of the metatarsophalangeal joint (big toe). Hallux rigidus, a type of big toe arthritis is a major cause of the same. According to a study published in the World Journal of Orthopedics in 2017, hallux rigidus is a degenerative disease of the first MTP joint. Moreover, it is estimated that the disease affects 1 in every 40 people, aged 50 or more. Females are greatly affected by the disease as compared to males, .i.e., by a ratio of 2:1. Â Therefore, increasing prevalence of hallux rigidus and growing female population are the major drivers for the market growth during the forecast period. Additionally, increasing demands for minimally invasive procedures and rising healthcare expenditure is estimated to fuel the market. According to the World Health Organization, the geriatric population is projected to grow from an estimated 524 million in 2010 to approximately 1.5 billion by 2050. However, high procedural cost followed by complications like deep vein thrombosis, need for repeated surgery, stiffness in the joints of the toes and low per capita healthcare expenditure in the middle and low-income countries is estimated to restrain the market growth during the projected period. According to the Fairfield Independent Hospital, the procedural cost for the same in 2016 was estimated to be around USD 3,545.
Intended Audience
- Pharmaceutical Companies
- Biotechnological Institutes
- Government and Private Laboratories
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Market Research and Consulting Service Providers
Figure 1:- Global Cheilectomy Market Share, by Region
 
Sources: WHO, annual reports, press release, white paper, and company presentation
 Segmentation:
The cheilectomy market is segmented by the method, anesthesia, medication, and end-user.
By the method, the cheilectomy market is segmented into open, arthroscopic, and percutaneous method.
By the anesthesia, the cheilectomy market is categorized into general anesthesia, local anesthesia, and regional anesthesia. By the medication, the market is segmented into prescription pain relievers, OCT, and others. By prescription the pain relievers the market is segmented into corticosteroids, opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and others. By the OCT drugs, the market is segmented into ibuprofen, naproxen, and others. By end users, the market is segmented into hospitals & clinics, academic institutes, retail pharmacies, and others.
Regional Analysis:
The Americas dominate the cheilectomy market owing to a well-developed healthcare sector and increasing the prevalence of hallux rigidus. Moreover, increasing healthcare expenditure and presence of the key players within the regions boosts the growth of the market in the Americas. Additionally, increasing geriatric population and growing female population fuels the regional market growth.
Europe is the second largest cheilectomy market, which is followed by Asia Pacific. Osteoarthritis is a common condition that may lead to hallux rigidus. Thus, increasing prevalence of the disease within the region drives the market growth. According to the Arthritis Research U.K in 2013, osteoarthritis was estimated to be the most common musculoskeletal condition in the geriatric population. Additionally, it was estimated that approximately, 8.75 million people within the region had sought some treatment for osteoarthritis.
Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India & China, and presence of huge opportunity in the market.
On the other hand, the Middle East & Africa has the least share in the cheilectomy market due to the presence of poor economy, especially in the Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.
Research Methodology
 
Sources: WHO, annual reports, press release, white paper, and company presentation
 Key players in cheilectomy market
The key players for the cheilectomy market are Henry Schein, Inc. (U.S.), STEROID S.p.A. (Italy), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), Sanofi (France), Janssen Pharmaceuticals, Inc. (Belgium), PurduePharma (U.S.), ALLERGAN (Republic of Ireland), Boehringer Ingelheim International GmbH (Germany), and others.
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
